In lung cancer [31] and in pancreatic adenocarcinoma [32], low CFB expression correlated with the presence of more aggressive tumours and a worse overall survival; consistently, in our cohort, SS showed the lowest CFB expression. The gene discussed is CFB; the disease is neoplasm.